A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy of full-dose gemcitabine in patients with unresectable locally advanced pancreatic carcinoma.

被引：0
|
作者：
Nagase, M [1 ]
Furuse, J [1 ]
Ishii, H [1 ]
Kawashima, M [1 ]
Ogino, T [1 ]
Yoshino, M [1 ]
机构：
[1] Natl Canc Ctr Hosp, Kashiwa, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4221
引用
收藏
页码：368S / 368S
页数：1
相关论文
共 50 条
  • [41] Interim Analysis of a Phase I Study of Veliparib With Gemcitabine and IMRT in Patients With Borderline and Locally Advanced Unresectable Pancreatic Cancer
    Tuli, R.
    Nissen, N. N.
    Lo, S.
    Tighiouart, M.
    Rogatko, A.
    Osipov, A.
    Bryant, M.
    Sandler, H. M.
    Hendifar, A. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E181 - E181
  • [42] Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma
    Ridwelski, K
    Fahlke, J
    Kuhn, R
    Hribaschek, A
    Kettner, E
    Greiner, C
    Florschuetz, A
    Manger, T
    Wilhelm, G
    Klein, H
    Hahnfeld, S
    Lippert, H
    Meyer, F
    EJSO, 2006, 32 (03): : 297 - 302
  • [43] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Tom Budiharto
    Karin Haustermans
    Eric Van Cutsem
    Werner Van Steenbergen
    Baki Topal
    Raymond Aerts
    Nadine Ectors
    Didier Bielen
    Dirk Vanbeckevoort
    Laurence Goethals
    Chris Verslype
    Radiation Oncology, 3
  • [44] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly Gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Budiharto, T
    Goethals, L
    Verslype, C
    Bielen, D
    Van Stenbergen, W
    Aerts, R
    Topal, B
    Van Cutsem, E
    Haustermans, K
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S273 - S273
  • [45] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Budiharto, Tom
    Haustermans, Karin
    Van Cutsem, Eric
    Van Steenbergen, Werner
    Topal, Baki
    Aerts, Raymond
    Ectors, Nadine
    Bielen, Didier
    Vanbeckevoort, Dirk
    Goethals, Laurence
    Verslype, Chris
    RADIATION ONCOLOGY, 2008, 3 (1)
  • [46] A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer
    M Ikeda
    S Okada
    K Tokuuye
    H Ueno
    T Okusaka
    British Journal of Cancer, 2002, 86 : 1551 - 1554
  • [47] A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer
    Ikeda, M
    Okada, S
    Tokuuye, K
    Ueno, H
    Okusaka, T
    BRITISH JOURNAL OF CANCER, 2002, 86 (10) : 1551 - 1554
  • [48] Phase I trial of fixed dose rate infusion (FDRI) gemcitabine (GEM) with gefitinib in patients with advanced pancreatic carcinoma.
    Carneiro, B
    Brand, R
    Fine, E
    Knop, R
    Khandekar, J
    Uhlig, W
    Locker, GY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 337S - 337S
  • [49] Hypofractionated intensity-modulated radiotherapy in locally advanced unresectable pancreatic cancer: A pilot study
    De Felice, Francesca
    Benevento, Ilaria
    Bulzonetti, Nadia
    Shima, Bianka
    Rubini, Filippo
    Marampon, Francesco
    Musio, Daniela
    Tombolini, Vincenzo
    CURRENT PROBLEMS IN CANCER, 2019, 43 (05) : 495 - 503
  • [50] Phase I trial of capecitabine and gemcitabine with radiotherapy in locally advanced pancreatic cancer
    Leong, T.
    Michael, M.
    Price, T.
    Ganju, V
    Strickland, A.
    Jefford, M.
    Muller, A.
    Ngan, S.
    Milner, A.
    Zalcberg, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
12345